122.09
前日終値:
$125.08
開ける:
$124.62
24時間の取引高:
6.38M
Relative Volume:
1.04
時価総額:
$212.30B
収益:
$43.84B
当期純損益:
$13.90B
株価収益率:
15.31
EPS:
7.9725
ネットキャッシュフロー:
$6.92B
1週間 パフォーマンス:
-4.62%
1か月 パフォーマンス:
-3.38%
6か月 パフォーマンス:
-8.60%
1年 パフォーマンス:
+5.61%
Abbott Laboratories Stock (ABT) Company Profile
名前
Abbott Laboratories
セクター
電話
(224) 667-6100
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ABT
Abbott Laboratories
|
122.09 | 217.50B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
93.84 | 144.57B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.60 | 139.21B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.26 | 129.94B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.32 | 50.02B | 5.88B | 1.34B | 799.60M | 2.3489 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-10 | 開始されました | The Benchmark Company | Buy |
| 2025-07-18 | アップグレード | Jefferies | Hold → Buy |
| 2025-06-16 | 開始されました | Leerink Partners | Market Perform |
| 2024-10-08 | 開始されました | Oppenheimer | Outperform |
| 2024-09-19 | 開始されました | Piper Sandler | Overweight |
| 2024-07-30 | ダウングレード | Edward Jones | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2023-07-21 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 繰り返されました | Barclays | Overweight |
| 2023-04-20 | 繰り返されました | Bernstein | Outperform |
| 2023-04-20 | 繰り返されました | JP Morgan | Overweight |
| 2023-04-20 | 繰り返されました | Raymond James | Outperform |
| 2023-04-20 | 繰り返されました | UBS | Buy |
| 2023-04-20 | 繰り返されました | Wolfe Research | Underperform |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-10-26 | 開始されました | Mizuho | Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-06 | 開始されました | Wolfe Research | Underperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-01-27 | 繰り返されました | Credit Suisse | Outperform |
| 2022-01-27 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-01-27 | 繰り返されました | Raymond James | Outperform |
| 2022-01-27 | 繰り返されました | UBS | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-10-27 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 開始されました | Redburn | Neutral |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Neutral |
| 2021-01-28 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Outperform |
| 2020-06-01 | ダウングレード | Goldman | Neutral → Sell |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Neutral |
| 2020-01-02 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-06-13 | 繰り返されました | BofA/Merrill | Buy |
| 2019-02-07 | 繰り返されました | BofA/Merrill | Buy |
| 2019-01-02 | ダウングレード | Citigroup | Neutral → Sell |
| 2018-11-30 | アップグレード | Goldman | Neutral → Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-01-30 | 繰り返されました | Citigroup | Neutral |
| 2018-01-25 | 繰り返されました | Stifel | Buy |
| 2018-01-25 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-10-19 | 繰り返されました | Stifel | Buy |
すべてを表示
Abbott Laboratories (ABT) 最新ニュース
Abbott (ABT) Expands Lingo Glucose Monitor to Android Users - GuruFocus
Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump - AOL.com
Abbott (NYSE: ABT) adds Lingo to Android, cites 15% lower odds of glucose spikes - Stock Titan
SVB Wealth LLC Has $12.17 Million Stake in Abbott Laboratories $ABT - MarketBeat
Divergent Views Emerge on Abbott Laboratories’ Stock Valuation - AD HOC NEWS
The Minnesotan behind Cologuard, which fueled the biggest health care acquisition of 2025 - Star Tribune
University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives - Finviz
Abbott (ABT) awards $1 million as Big Ten drive logs 83,043 blood donations - Stock Titan
Seaview Investment Managers LLC Purchases New Stake in Abbott Laboratories $ABT - MarketBeat
UBS Reaffirms Buy Rating on Abbott Laboratories (ABT) Amid Exact Sciences Acquisition - MSN
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga
Is Abbott Laboratories Fairly Priced After Growth In Devices And Diagnostics? - Yahoo Finance
FDA Warning For Abbott Glucose Sensors After 700 Injuries, 7 DeathsAbbott Laboratories (NYSE:ABT) - Benzinga
Healthtech Market Is Booming Worldwide With Boston Scientific, Philips Healthcare, Abbott Laboratories, - EIN News
Guggenheim Capital LLC Buys 11,794 Shares of Abbott Laboratories $ABT - MarketBeat
Assessing Abbott After 10.5% Gains and DCF PE Signals Amid Exact Sciences Deal Talk - simplywall.st
The Zacks Analyst Blog Highlights HSBC, Abbott, Shell and Oak Valley - Yahoo Finance
Arrowstreet Capital Limited Partnership Purchases 291,987 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (NYSE:ABT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Diabetes Glucose Monitors Recalled After 7 Deaths and More Than 700 Injuries - People.com
Top Analyst Reports for HSBC, Abbott & Shell - Yahoo Finance
Medtronic launches new diabetes tech integrated with Abbott sensor - Cardiovascular Business
FDA Issues Warning on Abbott (ABT) Glucose Monitors After Reported Deaths - GuruFocus
How Abbott Laboratories (ABL) stock trades after rate cuts2025 Trade Ideas & Fast Exit and Entry Trade Guides - Newser
Faulty Glucose Monitor Sensors May Be Tied to 7 Deaths, F.D.A. Says - The New York Times
Abbott Launches Two New Ensure Max Protein Shakes to Tap into Growing Muscle Health Movement - marketscreener.com
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and MoreResearchAndMarkets.com - The AI Journal
Muscles, the New Flex: Abbott Launches Two New Ensure Max Protein Shakes to Tap into Growing Muscle Health Movement - Finviz
Abbott (NYSE: ABT) debuts Ensure Max Protein 42g, 2 in 1 shakes with Walmart rollout - Stock Titan
Millions of Abbott Glucose Sensors Recalled After Faulty Readings Linked to Deaths - The Suburban
Abbott - The Pharma Letter
Don't Ignore The Insider Selling In Abbott Laboratories - simplywall.st
Abbott Laboratories $ABT Stake Lifted by First Trust Advisors LP - MarketBeat
Baird Financial Group Inc. Grows Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Medtronic launches insulin delivery system with Abbott-made sensor - MedTech Dive
Abbott Laboratories' (NYSE:ABT) Price Is Right But Growth Is Lacking - 富途牛牛
Seven States Join Abbott Infant Formula FCA Lawsuit, Alleging Years of Violations and Cover-Ups - USA Herald
Abbott Defends Glucose Monitor Patents In Sinocare Fight - Law360
Abbott Laboratories (NYSE: ABT) sees Vanguard report 10.05% beneficial stake - Stock Titan
The US Rollout of MiniMed 780G With Abbott's Sensor May Lift MDT Stock - sharewise.com
7 deaths, hundreds of injuries may be linked to diabetes glucose monitor errors, FDA says - CBS News
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
M&T Bank Corp Trims Stake in Abbott Laboratories $ABT - MarketBeat
Shelton Capital Management Has $8.97 Million Stake in Abbott Laboratories $ABT - MarketBeat
Loomis Sayles & Co. L P Raises Position in Abbott Laboratories $ABT - MarketBeat
Can Abbott Laboratories stock weather global recessionForecast Cut & AI Based Buy and Sell Signals - Newser
Invesco Ltd. Increases Stock Holdings in Abbott Laboratories $ABT - MarketBeat
States Hit Abbott With FCA Suit Over Infant Formula Recall - Law360
7 deaths linked to faulty blood glucose monitors as FDA issues safety warning - Fox Business
Seven deaths linked to malfunctioning glucose monitors - USA Today
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott - Medtronic
Abbott Laboratories (ABT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):